The company develops and sells luxury residential townships and mixed-use real estate projects, primarily under the Belmac brand, in the Pune and Panvel regions of India.
The company lacks a durable moat as evidenced by highly volatile revenue and deeply negative average net margins. While they operate under a specific brand, the real estate market is fragmented and the company's financial performance does not reflect any pricing power or cost advantage.
Management has focused on land acquisition and township development, but historical returns on capital are very low (3% ROCE). They have maintained a debt-free balance sheet recently, but have not demonstrated the ability to generate consistent shareholder value from reinvested earnings.
The company's inability to convert its land bank into cash flow proved fatal as the real estate cycle turned. Management continued to funnel capital into related-party transactions and inter-corporate deposits rather than productive assets, while the already abysmal 3% return on capital drifted toward zero. The lack of a brand moat meant they were price-takers in a cooling market, and the historical pattern of negative net margins became a permanent state of affairs, eventually forcing a fire sale of assets to cover operating overhead.
RichFakir rates Supreme Holdings & Hospitality Ltd's business quality as poor — 15/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Supreme Holdings & Hospitality Ltd is trading about 66% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Supreme Holdings & Hospitality Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Supreme Holdings & Hospitality Ltd's fair value is about ₹18 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →